The mesostriatal dopaminergic system influences locomotor activity and the reinforcing properties of many drugs of abuse including nicotine. Here we investigate the role of the a4 nicotinic acetylcholine receptor (nAChR) subunit in mediating the effects of nicotine in the mesolimbic dopamine system in mice lacking the a4 subunit. We show that there are two distinct populations of receptors in the substantia nigra and striatum by using autoradiographic labelling with 125 I a-conotoxin MII. These receptors are comprised of the a4, b2 and a6 nAChR subunits and non-a4, b2, and a6 nAChR subunits. Non-a4 subunit-containing nAChRs are located on dopaminergic neurons, are functional and respond to nicotine as demonstrated by patch clamp recordings. In vivo microdialysis performed in awake, freely moving mice reveal that mutant mice have basal striatal dopamine levels which are twice as high as those observed in wild-type mice. Despite the fact that both wild-type and a4 null mutant mice show a similar increase in dopamine release in response to intrastriatal KCl perfusion, a nicotine-elicited increase in dopamine levels is not observed in mutant mice. Locomotor activity experiments show that there is no difference between wild-type and mutant mice in basal activity in both habituated and nonhabituated environments. Interestingly, mutant mice sustain an increase in cocaine-elicited locomotor activity longer than wild-type mice. In addition, mutant mice recover from depressant locomotor activity in response to nicotine at a faster rate. Our results indicate that a4-containing nAChRs exert a tonic control on striatal basal dopamine release, which is mediated by a heterogeneous population of nAChRs.
Introduction
Locomotor activity and the reinforcing action of many drugs of abuse, including ethanol, cocaine, amphetamine and nicotine are influenced by the mesostriatal dopaminergic system (Koob, 1992) . The substantia nigra (SN) and ventral tegmental area (VTA) comprise the midbrain dopaminergic nuclei and regulate dopamine (DA) release in the striatum. Nicotinic acetylcholine receptors (nAChRs) are abundantly expressed in the SN and VTA (Clarke et al., 1985; Le Novère et al., 1996; Klink et al., 2001) . Tobacco smoking in humans and nicotine self-administration in animals are associated with an increase in dopamine release following the activation of nAChRs on mesencephalic DA neurons (Rose & Corrigall, 1997) . Doses of nicotine which are capable of producing self-administration in rodents, trigger specific increases in metabolism and in release of dopamine in the nucleus accumbens similar to those observed for strongly addictive drugs such as cocaine and amphetamines (Pontieri et al., 1996) . Furthermore, lesions of the mesolimbic dopaminergic neurons attenuate the locomotor-stimulating properties of nicotine (Clarke et al., 1988) and nicotine self-administration in rats (Corrigall et al., 1992) .
Many of the known nAChR subunits are located in the mesotelencephalic dopaminergic system (Le Novère et al., 1996; ArroyoJimenez et al., 1999) . The majority of dopaminergic neurons in the substantia nigra pars compacta (SNc) and VTA contain at least b2, b3, a3, a4, a5 and a6 nAChR subunit mRNA, and most GABAergic neurons in the same areas contain a4 and b2 nAChR subunit mRNA. Almost all (95%) of the neurons respond to acetylcholine by producing an inward nicotinic current (Klink et al., 2001) . Acetylcholine, the endogenous ligand of these receptors, is released by the cholinergic terminals from the pedunculopontine (PPTg) and laterodorsal (LDTg) tegmental nuclei (Hallanger et al., 1987; Lee et al., 1988; Bevan & Bolam, 1995; Oakman et al., 1995) and activates both the GABAergic and dopaminergic neurons in the SNc and VTA (Blaha et al., 1996; Forster & Blaha, 2000) .
The b2 subunit, present on both the DAergic and GABAergic neurons, has been shown to be an integral part of the nAChRs involved in nicotine reinforcement. For instance, microdialysis experiments showed that nicotine elicits a dose-dependent increase in striatal dopamine release in b2þ/þ but not in b2À/À mice. In vitro, low concentrations of nicotine (similar to those found in the arterial blood of smokers during cigarette consumption) elicited an increase in the discharge frequency of DAergic neurons on the SN and VTA in b2þ/þ animals but not in b2À/À mice. Both b2þ/þ and À/À mice are capable of learning cocaine self-administration. However, b2À/À mice rapidly cease self-administration activity when switched to nicotine. b2þ/þ mice continue this activity, suggesting that b2-containing (b2 Ã ) nAChRs contribute to the reinforcing properties of nicotine .
The a4 subunit is thought to assemble with the b2 subunit to form the major subtype of functional nAChRs in the central nervous system (CNS) with high-affinity for nicotine (Alkondon & Albuquerque, 1993) . However, in heterologous expression systems, the b2 nAChR subunit is also capable of assembling with other alpha subunits such as a3, a5 and a6 (Ramirez-Latorre et al., 1996; Gerzanich et al., 1997) and these functional subtypes could play a role in cholinergic nicotinic neurotransmission. The a4À/À mice provide a unique opportunity to examine the role of b2 Ã nAChRs lacking the a4 nAChR subunit in the CNS. We had previously shown that these mutant mice have normal levels of mRNA encoding other nAChR subunits. However, they lack most of the high affinity nicotine binding sites and have a reduced response to nicotine in antinociception tests . We used mice lacking the a4 subunit of the nAChR in order to investigate nicotine-elicited dopamine release and related behaviours and determine which subtypes of nAChRs regulate dopamine levels in response to systemically administered nicotine and, as a consequence, contribute to the properties of nicotine that are likely to be involved in tobacco consumption.
Methods

Animals
Mice for behavioural experiments were generated by mating parents heterozygous for a null mutation in the a4 nAChR subunit . The genotype of the offspring was determined by PCR, using oligonucleotides identifying the mutant and wild-type copies of the a4 gene. In each experiment, mice homozygous for the mutation in the a4 gene were paired with wild-type a4 mice of the same sex and age. For ligand binding, electrophysiology and microdialysis studies, homozygous mice were mated and the homozygous offspring were used. Double mutant mice with null mutations for both the a4 and b2 nAChR subunits were generated by crossing a4 and b2 homozygous mice followed by crossing the heterozygous progeny. To generate a large colony, mice homozygous for the null mutations were crossed. For the a4 null mutant line, mice were backcrossed from a 129SV background for 8 generations onto a C57Bl/6 background. Similarly, b2 null mutant mice were backcrossed for 10 generations.
Autoradiography
Unmodified a-conotoxin MII (a-CtxMII) was synthesized with the addition of a tyrosine at the N terminus (Y0-a-CtxMII) to provide an iodination site and 125 I-aCtxMII was generated as previously described (Whiteaker et al., 2000) .
Mice were anaesthetized with a lethal dose of pentobarbitol, decapitated, and brains were dissected out and frozen in crushed dry ice. Sections (18 mm) were cut on a cryostat (Reichert-Jung), mounted on Superfrostþ slides, and stored for 2-8 days at À80 8C until use. Sections were taken at 15 coronal levels [bregma levels: 1.2, 1.0, 0.4, À0.2, À0.5, À1.5, À2.0, À2.9, À3.4, À3.9, À4.8, À5.3, À5.8, À7.0, and À7.5 mm, according to Franklin & Paxinos (1997) ].
On the day of the experiment, the slides were thawed and processed according to established protocols Whiteaker et al., 2000) . 125 I-CtxMII was used at a concentration of 0.5 nM. Sections were preincubated for 15 min at room temperature in (in mM): 20 HEPES pH 7.4, 144 NaCl, 1.5 KCl, 2 CaCl 2 , 1 MgSO 4 and 0.1%BSA (protease-free). Slides were then incubated for 2 h at room temperature in preincubation buffer plus 0.5 nM 125 I aCTxMII, 5 mM EDTA, 5 mM EGTA and protease inhibitors (1 mM phenylmethylsulphonyl fluoride, 10 mg/mL aprotinin and 10 mg/mL leupeptin trifluoroacetate). Nonspecific binding was determined in the presence of an excess of unlabelled 10 mM epibatidine. Following incubation, the sections were dipped in ice cold 50 mM Tris pH 7.4, then washed (2 Â 1 min in ice cold Tris) and briefly rinsed in ice cold water.
125 I-epibatidine (2200 Ci/mmol, NEN) was used at a concentration of 50 pM. The concentration of 125 I-epibatidine (50 pM) was selected in order to bind all known nAChR subtypes, as a2b2 and a3b2 nAChR subtypes have a Kd of around 10 pM, a4b2 nAChR subtypes around 30 pM, a2b4 and a4b4 nAChR subtypes around 100 pM and a3b4 nAChR subtypes around 300 pM (Parker et al., 1998) . The incubation was carried out at room temperature for 30 min in 50 mM Tris HCl pH 7.4. It was followed by 2 rinses of 5 min in the same buffer followed by a brief rinse in distilled water, all carried out at 4 8C. Non-specific binding was defined as the binding in the presence of cold nicotine (10 mM).
Slides and Microscale autoradiography standards (Amersham) were exposed to 3 H-hyperfilm (Amersham) for 1-5 days and developed in Eastman Kodak (Rochester, NY) D19 film developer (4 min at 22 8C). At least five animals of each genotype were used for quantification. Quantitative receptor autoradiography was performed by means of computer-assisted microdensitometry (KS300 image analyser, Kontron, Munich, Germany) and by using appropriate standards. A semiquantitative densitometric evaluation of the sampled region was performed after assessment of the film response curve to radioactive standards, and the results were expressed in arbitrary densitometric units. Statistical analysis was performed according to the Mann-Whitney U-test.
Patch clamp in brain sections
Mice were anaesthetized with a lethal dose of pentobarbitol then immediately decapitated. Coronal 300 mm slices were obtained from the midbrain of wild-type (WT), and a4 null mutant mice (11-16 days old) incubated in oxygenated ACSF containing 1 mM kynurenic acid at $32 8C for 0.5 h, then left at room temperature for an additional 0.5 h. ACSF composition was as follows (in mM): 126 NaCl, 26 NaHCO 3 , 2.5 KCl, 2 CaCl 2 , 1.25 NaH 2 PO 4 , 1 MgCl 2 , 25 glucose. For recording, a single slice was transferred to a chamber superfused with oxygenated ACSF at 35 AE 0.5 8C at a rate of 2 mL/min. Wholecell recordings were obtained from SNc and VTA neurons identified using infrared videomicroscopy with Nomarski optics. Only presumptive projection neurons of large and medium size were targeted; presumputive interneurons of small size were avoided. Patch pipettes were filled with the following (in mM): 144 K-gluconate, 10 HEPES, 3 MgCl 2 , 0.2 EGTA, pH 7.2, yielding a 3-5 MO resistance. Recordings were done with an Axoclamp-2 A (Axon Instruments, Foster City, CA) amplifier operating under current-clamp or continuous voltage-clamp mode, filtered at 3 kHz, and stored on digital tape for later analysis. Data were subsequently acquired (10-50 kHz; InstruNet board, GWI, Sommerville, MA) and analysed (IgorPro software, ver 3.1, Wavemetrics, Lake Oswego, OR). Some traces were digitally filtered and the stimulus artifacts were removed for display (n ¼ 3-8 traces for all cell types). Univariate ANOVA was used for the statistical analysis.
Nicotine administration
Fast application of agonist was achieved by pressure-pulse delivery (14 psi) to a pressure application pipette (diameter 3.5-4 mm) positioned under visual control $30 mm from the targeted cell.
In vivo microdialysis in freely moving mice
Microdialysis and DA measurements were adapted from Malagié et al. (1996) . Concentric dialysis probes were made of cuprophan fibers. All probes (0.30 mm outer diameter) presented an active length of 2.0 mm. Mice (10-12 weeks old, 25-30 g body weight) were anaesthetized with chloral hydrate (400 mg/kg, i.p.) and implanted with the microdialysis probe in the ventral striatum according to the mouse brain atlas of Franklin & Paxinos (1997) (coordinates from bregma: anterior, 0; lateral, þ2.0; ventral, 4.5). The next day, after $20 h recovery from the surgery, the probe was perfused continuously with a microdialysis medium (composition in mM: NaCl 147, KCl 3.5, CaCl 2 1.26, MgCl 2 1.2, NaH 2 PO 4 1.0, NaHCO 3 25.0, pH 7.4) at a flow rate of 1.3 mL/min, using a CMA/100 pump (Carnegie Medicine, Stockholm, Sweden). Dialysate samples were collected every 15 min in small Eppendorf tubes for measurement of their DA content using HPLC (XL-ODS column; 4.6 Â 7.0 mm, particle size 3 mm; Beckman) coupled to an amperometric detector (1049 A; Hewlett-Packard, Les Ulis, France). Usually four samples were collected to determine basal values (means AESEM) before systemic administration of the drugs. The limit of sensitivity for DA was $0.5 fmol per sample (signal-to-noise ratio ¼ 2). Mice were injected i.p. with a solution of 0.5 or 1.0 mg/ kg of nicotine (free base) dissolved in 0.9% NaCl. Control animals received an injection of 0.9% NaCl (10 mL/kg, by the same route). Responses to drug administration were determined over a 120-min period. At the end of the experiments mice were anaesthetized with chloral hydrate (400 mg/kg i.p.) and then decapitated. The placement of the microdialysis probes was verified histologically (n ¼ 9-12 for each group). Statistical analysis was performed using a Student's t-test with genotype as the only variable.
Locomotor activity
A clear plastic cage 25.4 cm high, 45 cm long and 25.4 cm wide was used for all locomotor activity experiments. Movement was detected by eight infrared photobeam detectors and transducers set 1.5 cm above the floor of the apparatus and beam breaks were collected electronically. 3-7-month-old-male mice that were naive to the apparatus were used for novelty testing; activity was measured for 60 min, with time points being taken every 5 min (n ¼ 7 per group). For locomotion in a familiar environment, activity was measured after repeated exposure to the apparatus for 60 min at intervals of 20 min (n ¼ 10 per group). For all experiments, each mutant mouse was compared with a wild-type (þ/þ) sibling of the same sex from the same litter. Locomotion experiments were run by an observer blind to the genotype of the animals being tested. Tests were run from 10 a.m. to 5 p.m. Data are presented as mean AESEM. Statistical analysis was performed using a Student's t-test with genotype as the only variable ( Ã P < 0.05, ÃÃ P < 0.01 mutant compared with wild type for total number of beam breaks during a given time period). Nicotine (1 mg/kg), cocaine (15 mg/kg) and PBS were administered s.c.
Nicotine concentrations are expressed as free base throughout the text. All animal experimentation was conducted in accordance with the European Community Council Directive of 24 November 1986 (86/ 609/EEC).
Results
I-epibatidine autoradiography
As previously reported with 3 H-epibatidine Ross et al., 2000) , 125 I-epibatidine binding was markedly and unevenly decreased in the brains of a4À/À mice. In fact, persistent binding was observed only in a few regions belonging to the central visual pathway, the mesostriatal DA pathway, the habenulo-interpeduncular pathway, the inferior colliculus and medial vestibular nucleus. In the mesostriatal DA pathway of a4À/À mice, 15-20% and 5-10% of binding remained in cell body and terminal areas, respectively, relative to a4þ/þ controls (Fig. 1a) .
We then investigated the displacement of 125 I-epibatidine binding by cytisine in a4þ/þ and À/À mice. It has been shown that cytisineresistant nAChRs constitute a subpopulation of nAChRs specifically enriched in DA mesostriatal and visual pathways. In agreement with Marks et al. (1998) , in a4þ/þ mice 125 I-epibatidine binding sites resistant to low nM concentration of cytisine were concentrated in the central visual pathway, the mesostriatal DA pathway, the habenulointerpeduncular pathway, the inferior colliculus and the laterodorsal tegmentum, i.e. the areas where 125 I-epibatidine persists in a4À/À (Fig. 1b) . Accordingly, a significant positive correlation was present between the regional amount of 125 I-epibatidine binding in a4À/À mice and 125 I-epibatidine binding after displacement with 5 nM cytisine in a4þ/þ mice (Pearson correlation coefficient, r ¼ þ0.88, P ¼ 0.00036) (Fig. 1c) . Unlike the case in a4þ/þ mice, 125 I-epibatidine binding in SNc/VTA as well as caudate-putamen/n. accumbens of a4À/À mice was not displaced by low nM concentrations of cytisine, indicating that cytisine-resistant binding in the mesostriatal DA pathway corresponds to non-a4 Ã nAChRs (Fig. 2 ).
Finally, we tested 125 I-epibatidine binding sensitivity to aCtxMII in a4þ/þ and À/À mice. As shown by Whiteaker et al. (2000) , in a4þ/þ mice, only a few areas, including regions involved in central visual and mesostriatal DA pathways, showed partially reduced 125 I-epibatidine binding in the presence of aCtxMII (not shown). Instead, in a4À/À mice, 125 I-epibatidine binding was totally abolished in caudate-putamen and nucleus accumbens and markedly reduced in substantia nigra and ventral tegmental area, while 125 I-epibatidine binding in other nuclei, such as the inferior colliculus, was almost insensitive to aCtxMII displacement.
I aCtxMII autoradiography
It has recently been shown that high affinity aCtxMII binding corresponds to a6 Ã nAChRs as all binding disappears in a6À/À mice (Champtiaux et al., 2002) . Furthermore, there is a decrease in 125 IaCtxMII in some non-DA nuclei in a3À/À mice (Whiteaker et al., 2002) . In addition, aCtxMII can inhibit a3/b2-subunit-containing nAChR currents (Cartier et al., 1996) . Specific 125 I-aCtxMII binding was detected in both a4þ/þ and a4À/À but not in a4/b2À/À mouse brain sections (see Figs 3 and 4, and Table 1 ). In agreement with Whiteaker et al. (2000) , in WT mice, binding was observed at high levels in the superior colliculus (SC) (zonal and superficial grey layer), optic tract (opt), geniculate nucleus and olivary pretectal nucleus. Lower levels of binding were observed in the basal ganglia (including caudate putamen (CPu), olfactory tubercle (Tu) and nucleus accumbens (Acb), mesencephalic DAergic nuclei (SN/VTA), interpeduncular nucleus, medial habenula (MHb), lateral habenula, fasciculus retroflexus, and retina. These regions correspond to a6 nAChR subunit expressing regions and to their terminal fields (Champtiaux et al., 2002) .
In a4À/À mice, heterogeneous changes in 125 I-aCtxMII binding were observed. These changes were pathway-specific. Indeed, the habenulo-interpeduncular (MHb and IPn) and nigrostriatal (SNc and CPu) pathways did not show significant changes, the mesolimbic (VTA, Acb, Tu, LHb) and visual (olivary pretectal nucleus, dorsal and ventral lateral geniculate nuclei, and SC) pathways showed moderate to marked decreases (Table 1 and Fig. 4) . We next examined a4/b2À/À mice to see the effect of the additional deletion of the b2 nAChR subunit on 125 I-aCtxMII binding. The double knockout a4/ b2À/À mice showed a complete disappearance of 125 I-aCtxMII binding sites similar to that observed in a6À/À mice (Champtiaux et al., 2002) . These data suggest that two distinct nAChR subtype populations are present: one that comprises at least a6 and b2 subunits and another that comprises at least a4, a6 and b2 subunits.
Patch clamp recordings
In order to show that the receptors present in these regions were functional, i.e. responded to nicotine with an inward current, we obtained whole cell recordings of presumptive projection dopaminergic neurons of large and medium size in the SNc and VTA. DAergic neurons were distinguished from GABAergic neurons on the basis of intrinsic membrane potential and firing properties in response to current steps applied from À64 mV (Klink et al., 2001) . Pressure pulse application of 20 mM nicotine revealed an average inward current of 65 AE 5 pA and 35.5 AE 3.8 pA in VTA and SNc neurons, respectively, of a4þ/þ mice. In a4À/À mice no response was observed in 3 out of 7 neurons tested in the SNc, whereas all VTA neurons tested showed a response to nicotine application. Overall, nicotine elicited a significantly lower (%30% of WT values, univariate ANOVA: genotype, F ¼ 43.36, P < 0.001; region, F ¼ 11.29, P < 0.01; genotype Ã region, F ¼ 4.48, P < 0.05) inward current in dopaminergic neurons of a4À/À mice with respect to a4þ/þ mice (Table 2 and Fig. 5 ).
Microdialysis
Nicotine administered systemically acts by binding to nAChRs on either the cell soma in the substantia nigra and ventral tegmental area and/or nerve terminals in the dorsal and ventral (nucleus accumbens) striatum (Grady et al., 1992) therefore activating these cells and causing an increase in extracellular DA levels in the dorsal and ventral striatum (Pontieri et al., 1996) . This increase in DA release is related to the self-administration of nicotine and increased locomotor activity in habituated environments. Thus, we examined whether the nAChRs present in a4À/À mice were involved in eliciting the release of DA in the striatum of awake mice. A 300-mm (outer diameter) probe was implanted in the ventral and part of the dorsal striatum (Fig. 6c) and the mice were allowed to recover for 20 h. Surprisingly, the basal extracellular DA concentration in the dialysates of a4À/À mice was about twice as high as that found in a4þ/þ mice in all mice tested (a4À/À, 20.15 AE 1.6 fmol/20 mL, vs. a4þ/þ, 8.3 AE 0.95 fmol/20 mL, n ¼ 35) (Fig. 6a) . Nicotine was administered subcutaneously (s.c.) in awake mice and the dopamine concentration was measured in the dialysate for 120 min. Nicotine doses were chosen after testing in a4þ/þ mice which were at the seventh backcross onto a C57Bl/6 background; 0.125 mg/kg was ineffective in eliciting dopamine release thus the doses of 0.5 and 1 mg/kg were chosen. In a4þ/þ mice, these doses caused a peak increase of detectable DA of 30 and 100%, respectively. In contrast to the results obtained with wild-type mice, extracellular DA levels in the dialysates were not significantly changed in the striatum of a4À/À mice in response to any dose of nicotine tested (Fig. 7a-d) . However, DA release was elicited with KCl in both a4þ/þ and a4À/À mice demonstrating that the DAergic neurons in a4À/À mice are functional and are capable of eliciting a response (Fig. 6b) .
Locomotor activity
Systemic nicotine administration causes a decrease followed by an increase in locomotor activity in experimentally naive rats (Stolerman et al., 1973) (Stolerman et al., 1974) . This increase in activity is related to an increase in DA release in the striatum (Corrigall et al., 1994; Louis et al., 1998; Corrigall & Coen, 1991 ). Thus, we tested a4À/À mice for differences in locomotor activity after saline and nicotine administration. The basal activity of the a4þ/þ and a4À/À mice in both habituated and non-habituated environments did not differ. We next compared the effect of an acute dose of nicotine after mice had been habituated to the test cage for 1 h. Both the a4þ/þ and a4À/À mice experienced the locomotor depressant effect of nicotine. However, after 10 min, the a4À/À mice recovered from this effect and their activity returned to preinjection levels. The locomotor activity of a4þ/ þ mice remained depressed for at least 40 more minutes (Fig. 8a-c) . Several studies indicate that the locomotor-stimulating effect of cocaine is associated with an increase in dopamine transmission in the axonal terminal region of dopamine neurons (Kelly & Iversen, 1976; Nicola & Deadwyler, 2000) . Therefore we tested for differences in locomotor activity after acute administration of cocaine (15 mg/kg) in a4þ/þ and À/À mice. a4À/À mice had increased locomotor activity as measured by beam breaks 25-40 min after cocaine administration compared to a4þ/þ (Fig. 8d) .
Discussion
This present work describes the effects of the null mutation of the a4 nAChR subunit on the mesostriatal dopaminergic system. We investigated the nAChR subtype population and functionality in the SN and VTA by 125 I-aCtxMII binding, patch clamp recordings, and microdialysis experiments. As nicotine is known to influence locomotor activity through a dopaminergic dependent mechanism, we investigated whether basal locomotor activity in non-habituated and habituated environments was modified and the effect of acute nicotine administration in an habituated environment. . Striatal DA levels. Extracellular DA levels were measured by microdialysis in awake male mice aged 3-5 months. (a) Basal DA levels in a4À/À mice are higher than in a4þ/þ mice (n ¼ 35 and 35), Ã P < 0.05 when compared to wild-type controls by using an unpaired Student's t-test. (b) KCl-evoked DA release in a4þ/þ and a4À/À mice is similar. The buffer containing 3.5 mM KCl was replaced by one containing 120 mM KCl locally perfused via the dialysis probe for 15 min. Samples were then collected for an additional 60 min (c) Location of the concentric dialysis probe. Section through the striatum showing the track left by the microdialysis probe. The black arrow indicates the tip of the membrane. Probe was implanted in the ventral striatum with the following stereotaxic coordinates in mm, with respect to bregma: AP, 0; L, 2.0; D, À4.5 (Franklin & Paxinos, 1997) . CP, Caudate-putamen; GPI, Globus Pallidus interne; VL, lateral ventricle. Scale bar, 1 mm.
A heterogeneous nAChR population is present in dopaminergic nuclei
The majority of 125 I-epibatidine binding sites disappear in b2 nAChR null mutant mice. However, a subset of this binding persists in discrete CNS areas, suggesting that high affinity epibatidine binding sites are comprised of b2-containing nAChR subtypes and non-b2 nAChR subtypes . Previously, we showed that 3 H-epibatidine binding persisted in the SNc/VTA and the striatum of a4À/À mice despite a disappearance of these binding sites in b2À/À mice demonstrating that two distinct populations of nAChRs exist in these regions: b2/a4
Ã and b2/nona4 Ã . Further evidence for b2/non-a4 Ã nAChRs comes from cytisine displacement of 125 I-epibatidine. Cytisine-resistant epibatidine binding in a4þ/þwas observed in areas where 125 I-epibatidine persists in a4À/À mice. This binding in a4À/À mice is also resistant to low nM concentrations of cytisine. Furthermore, a significant positive correlation was observed between the regional amount of 125 I-epibatidine binding in a4À/À mice and 125 I-epibatidine binding after displacement with 5 nM cytisine in a4þ/þ mice, indicating that cytisineresistant binding in the mesostriatal DA pathway mostly corresponds to non-a4 Ã nAChRs (data not shown). The experiments with 125 IaCtxMII further elucidate the subunit receptor composition in these nuclei.
125 I-aCtxMII binding disappears in a6À/À (Champtiaux et al., 2002) and a4/b2À/À mice, but is only partially decreased in a4À/À mice (Figs 3 and 4) , suggesting that the a6 and b2 nAChR subunits are necessary components of this binding. Taken together, these data suggest that three nAChR subtype populations are present: one that is comprised of a4 and b2 subunits, one that contains at least a6 and b2 without a4, and another that is comprised of at least a4, a6 and b2 subunits. Therefore, a heterogeneous receptor population that could mediate behavioural effects of nicotine is present in mesostriatal nuclei (Fig. 9) . nAChRs in a4À/À mice produce a smaller, nicotine-elicited current
In wildtype mice, dopaminergic and GABAergic neurons in the SNc and VTA respond to nicotine and acetylcholine with an inward current (Pidoplichko et al., 1997; Picciotto et al., 1998; Klink et al., 2001) . When the b2 nAChR subunit is no longer present in these neurons, as in the case of b2À/À mice, no nicotine or acetylcholine-elicited slow current is detected in dopaminergic neurons or GABAergic neurons of the SNc or VTA Klink et al., 2001 ) but occasionally a quickly desensitizing current, corresponding to a7 subunit-containing-nAChR, is detected in these neurons (Klink et al., 2001) . In contrast, in dopaminergic neurons of a4À/À mice, a nicotine-elicited (Fig. 5 ) and acetylcholine-elicited (Klink et al., 2001) inward current is detected. The ACh current amplitude, rise time and decay time are all significantly smaller than in wildtype mice (Klink et al., 2001 ). These data demonstrate that the nAChR subunits remaining in a4À/À mice are capable of forming functional nAChRs, albeit the main native receptor subtype is a4 and b2 Ã . The remaining current is most likely to be b2 Ã as no current is detected in b2À/À mice. b3, a5, a6 and a3 subunits which have been detected by singlecell RT-PCR in dopaminergic neurons (Klink et al., 2001 ) are also 9 . Model of the distribution of nAChRs in the mouse SNc and VTA and striatum. nAChR subunits are differentially distributed on DA and GABAergic neurons in the SN and VTA. Only a4 and b2 nAChR subunits are found on GABAergic neurons, whereas the DA neurons also express a3, a5, a6 and b3 (Klink et al., 2001) . Cholinergic afferents to the SNc/VTA arrive via the pedunculopontine (PPTg) and laterodorsal (LDTg) tegmental nuclei (Hallanger et al., 1987; Lee et al., 1988; Bevan & Bolam, 1995; Oakman et al., 1995) resulting in the striatal release of DA (Forster & Blaha, 2000) . nAChRs in the dopaminergic system 1335 probable components of this remaining current. In Xenopus oocytes, the a6 nAChR subunit does not form functional receptors when coexpressed with only the b2 subunit (Kuryatov et al., 2000) . The b3 and a5 nAChR subunits, which show a high sequence homology to one another, form functional receptors only when another a and another b subunit are present (Ramirez-Latorre et al., 1996; Sivilotti et al., 1997; Groot-Kormelink et al., 1998; Nelson & Lindstrom, 1999) . When b3, a5, b2 and a6 are coexpressed, a rapidly desensitizing current is observed. The a6 subunit can also form functional receptors with b2 and a3, and can modify the biophysical properties when compared to a3 and b2 alone (Kuryatov et al., 2000) .
Basal DA levels in a4À/À mice are elevated Under normal conditions, a baseline level of dopamine (DA) is released into the striatum from the dopaminergic projecting neurons of the SNc and VTA. Nicotine administered systemically causes an increase in extracellular DA levels in the dorsal and ventral striatum via an excitation of these dopaminergic neurons (Pontieri et al., 1996) . In vivo studies have shown that nicotine self-administration and striatal dopamine release is reduced by lesions of this mesolimbic pathway or by nicotinic antagonists microinfused into the VTA (Clarke et al., 1988; Corrigall & Coen, 1991; Corrigall et al., 1994) . The b2 nAChR subunit is important in mediating these effects of nicotine. This subunit is normally located on the cell soma of neurons in the SNc and VTA but, when it is not present in b2 null mutant mice, no nicotine-elicited increase in DA release is observed . Similarly, in a4À/À mice, no nicotine-elicited increase in DA release is observed. Surprisingly, the basal extracellular DA concentration in the striatum of a4À/À mice was about twice as high as that found in the a4þ/þ mice. In the SNc and VTA, %90% of the neurons are dopaminergic and most of the rest are GABAergic projection and interneurons. The GABA receptor antagonist, picrotoxin, increases DA release in the striatum when infused into the VTA. This increase is attenuated with muscimol, a GABA receptor agonist (Ikemoto et al., 1997) , suggesting that DA neurons projecting from the VTA to the Acb are tonically inhibited by GABA through its actions at GABA receptors.
Cholinergic innervation of the SNc/VTA occurs through the PPTg and LDTg nuclei, which send ascending projections to the SN and VTA (Hallanger et al., 1987; Lee et al., 1988; Bevan & Bolam, 1995; Oakman et al., 1995) resulting in the striatal release of DA (Blaha et al., 1996; Forster & Blaha, 2000) . At least six of the identified nicotinic acetylcholine receptor subunits are expressed in mesencephalic dopaminergic neurons (a3, a4, a5, a6, a7, b2 and b3), whereas only a4 and b2 nAChR subunits are expressed in most VTA GABAergic neurons (Klink et al., 2001) .
In a4À/À, we see a loss of functional nAChRs on GABAergic neurons (Klink et al., 2001) but not on DA neurons (Fig. 5) (Klink et al., 2001) which presumably results in the loss of nicotinic modulation on GABAergic neurons. However, functional nAChRs in the DA neurons can continue to respond to the cholinergic inputs (Fig. 7) . This is different from what was observed in b2À/À mice, where no functional nAChRs remained in either DA or GABAergic neurons resulting in the complete loss of cholinergic activation Klink et al., 2001) .
These data suggest that DA release is controlled by a delicate balance between functional nAChRs on GABAergic neurons and on dopaminergic neurons, and that a loss of nAChR ion channel function can cause an imbalance. Importantly, other neuronal cell types and nAChRs are also involved in this system. Mansvelder & McGehee (2000) have demonstrated that nicotine application can cause longterm synaptic changes by enhancing the release of glutamate from inputs to the VTA. This synaptic plasticity was shown to be mediated by a presynaptic, MLA-sensitive nAChR thus implicating a7 nAChRs in DA release in the striatum. a4À/À mice recover from the depressant effects of nicotine faster and are more sensitive to cocaine Systemic nicotine administration causes a decrease followed by an increase in locomotor activity in experimentally naive rats (Stolerman et al., 1973; Stolerman et al., 1974) , which is related to an increase in DA release in the striatum (Corrigall & Coen, 1991; Corrigall et al., 1994; Louis et al., 1998) . However, this stimulatory effect of nicotine is difficult to reproduce in mice; a4À/À mice were tested for differences in locomotor activity after saline and nicotine administration. In contrast to Ross et al. (2000) , the basal activity of the a4þ/þ and a4À/À mice in both habituated and non-habituated environments did not differ suggesting that the increase in striatal DA levels was not high enough to cause a locomotor behavioural phenotype in this particular backcross. Both the a4þ/þ and a4À/À mice experienced the locomotor depressant effect of an acute injection of nicotine. However, after 10 min, the a4À/À mice recovered from this effect and their activity returned to preinjection levels. The locomotor activity of a4þ/ þ mice remained depressed for at least 40 more minutes.
Differences in locomotor activity after acute administration of cocaine (15 mg/kg) in a4þ/þ and À/À mice were tested because the locomotor-stimulating effect of cocaine is associated with an increase in dopamine transmission in the axonal terminal region of dopamine neurons (Kelly & Iversen, 1976; Nicola & Deadwyler, 2000) . An acute injection of cocaine increased locomotor activity in a4þ/þ and À/À mice. However, this effect was longer lasting in the a4À/À mice.
Conclusions
Our results suggest that the a4 Ã nAChR exerts a tonic control on striatal basal DA release, which is mediated by a heterogeneous population of nAChRs. In the SN and VTA, nAChR subunits are differentially distributed on DA and GABAergic neurons. Deleting the a4 nAChR eliminates functional nAChRs from the GABAergic neurons (Klink et al., 2001 ) in a manner similar to the effect in b2À/À mice , whereas functional nAChRs remain in the DA neurons (unlike those in b2À/À mice) (Klink et al., 2001) . The a4 and b2 nAChR subunits form the predominant nAChR subtype in this system. However, other alpha subunits can form functional nAChRs with the b2 subunit. The observed differences between a4 null mutant mice and wild-type controls, in basal dopamine levels and sensitivity to nicotine and cocaine in locomotor activity tests, could be due to the differential distribution of nAChR subunits on DA and GABAergic neurons in the SN and VTA.
